By Mellanie True Hills Summary: The FDA has approved a second alternative to warfarin, Xarelto (rivaroxaban), for stroke prevention in atrial fibrillation. Approximate reading time: 2–4 minutes November 4, 2011 — The U.S. Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those who have non-valvular atrial fibrillation (afib that is …
Read MoreAll News
By Mellanie True Hills October 24, 2011 Summary: This video discusses the CHA2DS2-VASc tool for predicting stroke risk in atrial fibrillation and why aspirin should not be used for stroke prevention. Reading and watching time is approximately 10 minutes In this video interview, Dr. Gregory Lip, Professor of Cardiovascular Medicine at the University of Birmingham …
Read MoreOctober 17, 2011 Summary: Take advantage of this unique opportunity to chat live on October 28, 2011, with atrial fibrillation experts from the Cleveland Clinic and the founder of StopAfib.org. Our previous chat with doctors from the Cleveland Clinic was so popular that they have agreed to do another one. Please join us on October …
Read MoreSeptember 28, 2011 Summary: Raising afib awareness is intensely personal for StopAfib.org founder, Mellanie True Hills, which led her to create Atrial Fibrillation Awareness Month. Dallas, TX — September 2011 is the fifth annual Atrial Fibrillation Awareness Month. Raising afib awareness is intensely personal for StopAfib.org founder, Mellanie True Hills, and led her to create …
Read MoreSeptember is Atrial Fibrillation Awareness Month. Lots of folks don’t know too much about the condition, which is an irregular heart beat that can lead to serious complications such as dementia, heart failure, stroke or even death. To help spread the word, StopAfib.org presents 10 afib facts and figures that will probably surprise even some …
Read MoreBy Mellanie True Hills September is Atrial Fibrillation Awareness Month. Why do we need a month devoted to afib? In my opinion piece, Atrial Fibrillation Month Raises Awareness about this Common, Yet Unknown Condition, I share why I started Atrial Fibrillation Awareness Month four years ago and why I have helped lead this awareness campaign. …
Read MoreCidade do México, 8 de setembro de 2011 – É necessário haver uma medida coordenada urgente por parte de governos nacionais, sociedades médicas e organização de pacientes para evitar uma crise na saúde pública decorrente de uma tendência de derrames passíveis de prevenção que deixam muitos indivíduos com fibrilação atrial (FA) incapacitados mental ou fisicamente …
Read MoreCiudad de México, 8 de septiembre de 2011 – Se necesita acción coordinada urgente de gobiernos nacionales, sociedades médicas y organizaciones de pacientes para evitar una crisis de la salud pública como resultado de la ola de apoplejías evitables que deja a muchas personas que padecen de fibrilación auricular (FA) mental y físicamente discapacitadas o …
Read MoreBy Jennifer L.W. Fink Summary: An FDA panel voted to recommend approval of rivaroxaban (Xarelto) for stroke prevention in atrial fibrillation. Approximate reading time: 3–5 minutes Adelphi, MD, September 8, 2011 — An FDA panel voted 9-2-1 to recommend approval of rivaroxaban (Xarelto) for reducing the risk of stroke in those with atrial fibrillation (afib). …
Read MoreMexico City, 8 September 2011 – Urgent coordinated action from national governments, medical societies and patient organizations is needed to avoid a public health crisis resulting from the tide of preventable strokes that leave many people with atrial fibrillation (AF) mentally and physically disabled or dead, every year. How Can We Avoid a Stroke Crisis …
Read More